One Dose of Lilly’s Novel Heart Drug Cut Risk Factors for a Year

U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug

Paulson’s $1 Billion Caribbean Empire Faces Crisis and Betrayal

Analysis-FTC settlement could shelter Amgen from US price cuts, taxes

Amgen settles with the FTC over $28 billion deal

Amgen gets US FTC's go-ahead for $27.8 billion Horizon deal

Amgen-Horizon Takeover Seen Close to a Lock After FTC Pauses Challenge

US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics

California, other states join FTC bid to block Amgen deal

Popular Hedge-Fund Trade Draws Fresh Scrutiny as Debt Battle Rages On

FTC effort to stop Amgen's Horizon takeover faces uphill fight

U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents